Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Dana Chase

Gyn Onc · UCLA

View

Dr. Kimberly Resnick

Gyn Onc · MetroHealth

View

Dr. Ashley Stuckey

Gyn Onc · Women & Infants Hospital

View

Dr. Susan Khalil

MIGS · ISMMS

View

Dr. Tori O’Daniel

OB Hospitalist · Laborie-MCH division, Senior Medical Director

View

Dr. Alissa Erogbogbo

OB Hospitalist · Washington Health System

View

Dr. Christina Adams

OB Hospitalist · Flagler Hospital

View

Dr. Brigid McCue

OB Hospitalist · Northwell Health

View

Dr. Bruce Bekkar

General OBGYN · ecoAmerica

View

Dr. Jennifer Lincoln

OB Hospitalist · Providence

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    SMDr. Shannon MacLaughlan David

    Dr. Shannon MacLaughlan David

    Obstetrics & Gynecology (OBGYN) · Gynecologic Oncology
    SMacDavidMD, LLC
    shannon
    Chicago, IL, USA

    Research

    Safety and feasibility of talimogene laherparepvec in peritoneal surface malignancies: Results from the TEMPO trial.

    2025

    Via Molecular Therapy. Oncology

    Research

    Increased Local Testosterone Levels Alter Human Fallopian Tube mRNA Profile and Signaling.

    2023

    Via Cancers (Basel)

    Research

    Proteomic Profiling of Fallopian Tube-Derived Extracellular Vesicles Using a Microfluidic Tissue-on-Chip System.

    2023

    Via Bioengineering (Basel)

    Research

    HE4 (WFDC2) gene overexpression promotes ovarian tumor growth.

    2014

    Via Scientific Reports

    Research

    Expression profiling of primary and metastatic ovarian tumors reveals differences indicative of aggressive disease.

    2014

    Via PLOS One

    Research

    Necrotizing infection of the breast after core needle biopsy.

    2013

    Via The Breast Journal

    Research

    Identification of ovarian cancer metastatic miRNAs.

    2013

    Via PLOS One

    Research

    PT19c, Another Nonhypercalcemic Vitamin D2 Derivative, Demonstrates Antitumor Efficacy in Epithelial Ovarian and Endometrial Cancer Models.

    2013

    Via Genes & Cancer

    Research

    Correlation between smoking status and cervical cancer screening: a cross-sectional study.

    2011

    Via Journal of Lower Genital Tract Disease

    Research

    Current clinical use of biomarkers for epithelial ovarian cancer.

    2010

    Via Current Opinion in Oncology

    Research

    Current state of biomarker development for clinical application in epithelial ovarian cancer.

    2009

    Via Gynecologic Oncology

    Research

    Endometrial expression of Cyr61: a marker of estrogenic activity in normal and abnormal endometrium.

    2007

    Via Obstetrics and Gynecology